Bolt Biotherapeutics Ownership | Who Owns Bolt Biotherapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Bolt Biotherapeutics Ownership Summary


Bolt Biotherapeutics is owned by 59.43% institutional investors, 3.46% insiders, and 37.11% retail investors. Tang capital management is the largest institutional shareholder, holding 10.02% of BOLT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.25% of its assets in Bolt Biotherapeutics shares.

BOLT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBolt Biotherapeutics59.43%3.46%37.11%
SectorHealthcare Stocks 47.38%7.99%44.63%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tang capital management3.81M10.02%$2.86M
Vivo capital3.52M9.25%$2.64M
Sofinnova investments2.75M7.24%$2.07M
Citadel advisors2.37M6.22%$1.78M
Pivotal bioventure partners investment advisor1.89M4.97%$1.42M
Newtyn management1.36M3.58%$1.02M
Nan fung group1.17M3.07%$875.21K
Vanguard group1.07M2.80%$800.55K
Samsara biocapital1.05M2.76%$786.87K
Board of trustees of the leland stanford junior university719.55K1.89%$539.66K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pivotal bioventure partners investment advisor1.89M1.09%$1.42M
Nan fung group1.17M0.93%$875.21K
Tang capital management3.81M0.29%$2.86M
Vivo capital3.52M0.24%$2.64M
Newtyn management1.36M0.19%$1.02M
Samsara biocapital1.05M0.16%$786.87K
Sofinnova investments2.75M0.11%$2.07M
Board of trustees of the leland stanford junior university719.55K0.04%$539.66K
Adar1 capital management186.00K0.03%$139.50K
Bridgeway capital management85.20K0.00%$63.90K

Top Buyers

HolderShares% AssetsChange
Tang capital management3.81M0.29%392.77K
Adar1 capital management186.00K0.03%181.00K
Jane street group41.53K-41.53K
Ubs group48.83K-36.65K
Assenagon asset management34.49K0.00%34.49K

Top Sellers

HolderShares% AssetsChange
Orbimed advisors---1.54M
Acuitas investments---630.51K
Newtyn management1.36M0.19%-336.77K
Renaissance276.74K0.00%-240.90K
Marquette asset management---113.80K

New Positions

HolderShares% AssetsChangeValue
Assenagon asset management34.49K0.00%34.49K$25.87K
Susquehanna group, llp22.41K-22.41K$16.81K

Sold Out

HolderChange
Qube research-2.00
Wells fargo & company/mn-211.00
Steward partners investment advisory-1.00K
Virtu financial-10.94K
Xtx topco-12.83K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202435-5.41%22,625,732-5.73%591.48%1660.00%6-45.45%
Mar 31, 202437-2.63%24,001,384-0.52%631.56%10-33.33%11-8.33%
Dec 31, 20233815.15%24,125,809-1.70%631.51%1550.00%1250.00%
Sep 30, 202333-17.50%24,542,560-2.54%651.46%10-28.57%8-11.11%
Jun 30, 202340-25,183,1067.98%661.74%14-22.22%950.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv861.87K2.25%-
Vanguard Institutional Extnd Mkt Idx Tr205.54K0.54%-
Fidelity Extended Market Index149.94K0.39%-606.00
Fidelity Total Market Index108.27K0.28%-18.68K
Bridgeway Ultra-Small Company Market85.20K0.22%-
Fidelity Enhanced Small Cap ETF82.00K0.21%-572.00
iShares Micro-Cap ETF70.16K0.18%-
Fidelity Series Total Market Index29.67K0.08%-
Fidelity VIP Disciplined Small Cap Init27.70K0.07%-
NT Ext Equity Mkt Idx Fd - L25.89K0.07%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 12, 2023Quinn William P. Chief Financial OfficerBuy$7.13K
Jun 06, 2023Quinn William P. Chief Financial OfficerBuy$2.16K
Dec 06, 2023Quinn William P. Chief Financial OfficerBuy$1.96K
Nov 30, 2023ENGLEMAN EDGAR-Sell$92.80K
Nov 29, 2023ENGLEMAN EDGAR-Sell$20.54K

Insider Transactions Trends


DateBuySell
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q4224
2023 Q21-

BOLT Ownership FAQ


Who Owns Bolt Biotherapeutics?

Bolt Biotherapeutics shareholders are primarily institutional investors at 59.43%, followed by 3.46% insiders and 37.11% retail investors. The average institutional ownership in Bolt Biotherapeutics's industry, Biotech Stocks , is 45.43%, which Bolt Biotherapeutics exceeds.

Who owns the most shares of Bolt Biotherapeutics?

Bolt Biotherapeutics’s largest shareholders are Tang capital management (3.81M shares, 10.02%), Vivo capital (3.52M shares, 9.25%), and Sofinnova investments (2.75M shares, 7.24%). Together, they hold 26.50% of Bolt Biotherapeutics’s total shares outstanding.

Does Blackrock own Bolt Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of Bolt Biotherapeutics.

Who is Bolt Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Pivotal bioventure partners investment advisor is Bolt Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 1.09% of its assets in 1.89M Bolt Biotherapeutics shares, valued at 1.42M$.

Who is the top mutual fund holder of Bolt Biotherapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Bolt Biotherapeutics shares, with 2.25% of its total shares outstanding invested in 861.87K Bolt Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools